BR0007729A - Compound, pharmaceutical composition, and methods of controlling bacterial infections in a host in need of such therapy, and preparation of a compound - Google Patents
Compound, pharmaceutical composition, and methods of controlling bacterial infections in a host in need of such therapy, and preparation of a compoundInfo
- Publication number
- BR0007729A BR0007729A BR0007729-1A BR0007729A BR0007729A BR 0007729 A BR0007729 A BR 0007729A BR 0007729 A BR0007729 A BR 0007729A BR 0007729 A BR0007729 A BR 0007729A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- therapy
- pharmaceutical composition
- methods
- need
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
Abstract
"COMPOSTO, COMPOSIçãO FARMACêUTICA, E, MéTODOSDE CONTROLE DE INFECçõES BACTERIANAS EM UMHOSPEDEIRO EM NECESSIDADE DE TAL TERAPIA, E DEPREPARO DE UM COMPOSTO". São fornecidos compostostendo as fórmulas (I) e (II) em que n é O ou 1 e, quando n = 1, R éum anel heterocíclico de 5 ou 6 membros, hidróxi, halogênio, oxo,carbamoíla, alcóxi ou amino dissubstituído, quando n = 0, R é umgrupo éster, ciano ou amida; X é CH ou NH; ~ 3~é ciano, metóxiou acetamido; R~ 1~, é hidrogênio, alquila, uma carga negativa,um cátion selecionado do grupo consistindo de sódio, potássio etetraalquilamónio e aciloxialquila, ou alcoxicarboniloxialquila; e R~2~ é hidrogênio, acila, carbamoíla, silila trissubstituída ou umresíduo de aminoácido; ou seus sais farmaceuticamenteaceitáveis."COMPOUND, PHARMACEUTICAL COMPOSITION, AND, METHODS OF CONTROL OF BACTERIAL INFECTIONS IN A HOUSEHOLDER IN NEED OF SUCH THERAPY, AND DEPREPARATION OF A COMPOUND". They are provided comprising the formulas (I) and (II) in which n is O or 1 and, when n = 1, R is a 5- or 6-membered heterocyclic ring, hydroxy, halogen, oxo, carbamoyl, alkoxy or disubstituted amino, when n = 0, R is an ester, cyano or amide group; X is CH or NH; ~ 3 ~ is cyano, methoxy or acetamido; R ~ 1 ~, is hydrogen, alkyl, a negative charge, a cation selected from the group consisting of sodium, potassium etetraalkylammonium and acyloxyalkyl, or alkoxycarbonyloxyalkyl; and R ~ 2 ~ is hydrogen, acyl, carbamoyl, trisubstituted silyl or an amino acid residue; or their pharmaceutically acceptable salts.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23772699A | 1999-01-26 | 1999-01-26 | |
PCT/US2000/001630 WO2000043399A1 (en) | 1999-01-26 | 2000-01-26 | 3,6-disubstituted penam sulfone derivatives as antibacterials |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0007729A true BR0007729A (en) | 2001-10-30 |
Family
ID=22894903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0007729-1A BR0007729A (en) | 1999-01-26 | 2000-01-26 | Compound, pharmaceutical composition, and methods of controlling bacterial infections in a host in need of such therapy, and preparation of a compound |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1144418A1 (en) |
JP (1) | JP2002535335A (en) |
KR (1) | KR20010101649A (en) |
CN (1) | CN1188417C (en) |
AU (1) | AU2624600A (en) |
BG (1) | BG105737A (en) |
BR (1) | BR0007729A (en) |
CA (1) | CA2355738A1 (en) |
CZ (1) | CZ20012691A3 (en) |
EA (1) | EA200100813A1 (en) |
HK (1) | HK1038747A1 (en) |
HU (1) | HUP0200013A3 (en) |
ID (1) | ID29400A (en) |
IL (1) | IL144116A0 (en) |
NO (1) | NO20013640D0 (en) |
PL (1) | PL349874A1 (en) |
SK (1) | SK10142001A3 (en) |
TR (1) | TR200102133T2 (en) |
WO (1) | WO2000043399A1 (en) |
ZA (1) | ZA200104323B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2406267B1 (en) * | 2009-03-10 | 2019-02-20 | L'Air Liquide Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Cyclic amino compounds for low-k silylation |
CN109422765B (en) * | 2017-09-05 | 2020-08-28 | 香港理工大学深圳研究院 | C-class beta-lactamase inhibitor and preparation method and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2076812A (en) * | 1980-05-22 | 1981-12-09 | Ciba Geigy Ag | Penam-dioxide compounds, processes for their manufacture, and their use |
EP0083977A1 (en) * | 1982-01-11 | 1983-07-20 | Pfizer Inc. | 6-Alpha-hydroxymethylpenicillanic acid sulfone as a beta-lactamase inhibitor |
US4562073A (en) * | 1982-12-24 | 1985-12-31 | Taiho Pharmaceutical Company Limited | Penicillin derivatives |
US4503040A (en) * | 1984-02-27 | 1985-03-05 | Pfizer Inc. | 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors |
US4591459A (en) * | 1984-12-03 | 1986-05-27 | Pfizer Inc. | Intermediates for 6-(aminoacyloxymethyl) penicillanic acid 1,1-dioxides |
TW383308B (en) * | 1993-08-24 | 2000-03-01 | Hoffmann La Roche | 2-beta-alkenyl penam sulfones as beta-lactamase inhibitors |
-
2000
- 2000-01-26 IL IL14411600A patent/IL144116A0/en unknown
- 2000-01-26 AU AU26246/00A patent/AU2624600A/en not_active Abandoned
- 2000-01-26 HU HU0200013A patent/HUP0200013A3/en unknown
- 2000-01-26 PL PL00349874A patent/PL349874A1/en not_active Application Discontinuation
- 2000-01-26 CN CNB008030766A patent/CN1188417C/en not_active Expired - Fee Related
- 2000-01-26 JP JP2000594815A patent/JP2002535335A/en active Pending
- 2000-01-26 EP EP00904498A patent/EP1144418A1/en not_active Withdrawn
- 2000-01-26 CZ CZ20012691A patent/CZ20012691A3/en unknown
- 2000-01-26 ID IDW00200101522A patent/ID29400A/en unknown
- 2000-01-26 BR BR0007729-1A patent/BR0007729A/en not_active IP Right Cessation
- 2000-01-26 TR TR2001/02133T patent/TR200102133T2/en unknown
- 2000-01-26 SK SK1014-2001A patent/SK10142001A3/en unknown
- 2000-01-26 KR KR1020017009276A patent/KR20010101649A/en not_active Application Discontinuation
- 2000-01-26 EA EA200100813A patent/EA200100813A1/en unknown
- 2000-01-26 CA CA002355738A patent/CA2355738A1/en not_active Abandoned
- 2000-01-26 WO PCT/US2000/001630 patent/WO2000043399A1/en not_active Application Discontinuation
-
2001
- 2001-05-25 ZA ZA200104323A patent/ZA200104323B/en unknown
- 2001-07-24 NO NO20013640A patent/NO20013640D0/en not_active Application Discontinuation
- 2001-07-26 BG BG105737A patent/BG105737A/en unknown
-
2002
- 2002-01-10 HK HK02100179.1A patent/HK1038747A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HK1038747A1 (en) | 2002-03-28 |
BG105737A (en) | 2002-05-31 |
CZ20012691A3 (en) | 2002-06-12 |
TR200102133T2 (en) | 2001-12-21 |
EA200100813A1 (en) | 2003-02-27 |
IL144116A0 (en) | 2002-05-23 |
EP1144418A1 (en) | 2001-10-17 |
AU2624600A (en) | 2000-08-07 |
HUP0200013A2 (en) | 2002-05-29 |
NO20013640L (en) | 2001-07-24 |
HUP0200013A3 (en) | 2002-10-28 |
PL349874A1 (en) | 2002-09-23 |
KR20010101649A (en) | 2001-11-14 |
WO2000043399A1 (en) | 2000-07-27 |
ID29400A (en) | 2001-08-30 |
ZA200104323B (en) | 2002-08-26 |
SK10142001A3 (en) | 2002-07-02 |
JP2002535335A (en) | 2002-10-22 |
CN1337965A (en) | 2002-02-27 |
NO20013640D0 (en) | 2001-07-24 |
CN1188417C (en) | 2005-02-09 |
CA2355738A1 (en) | 2000-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2188194T3 (en) | 1,8-NAFTIRIDIN-4 (1H) -ONON REPLACED AS INHIBITORS OF PHOSPHODESTERASE 4. | |
AR011093A1 (en) | COMPOUNDS DERIVED FROM SULFONIL UREA, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND PROCEDURE FOR ITS USE. | |
BG93979A (en) | N-(4-PIPERIDINYL)(DIHYDROBENZOFURAN OR DIHYDRO-2H-BENZOPYRAN)CARBOXAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THEM, METHOD OF PREPARING THE DERIVATIVES AND THEIR APPLICATION | |
DE69920509D1 (en) | PYRIMIDINE CONNECTIONS | |
ES8800150A1 (en) | 5-substituted-3-aminoalkyl indole derivatives for migraine | |
ES8606306A1 (en) | Benzoxazol- and benzothiazolamine derivatives. | |
AP9801378A0 (en) | 9-amino-3- keto erythromycin derivatives. | |
NO324229B1 (en) | 2-hydroxymutiline carbamate derivatives, their use, pharmaceutical composition and process for preparing such a compound | |
HUP0203184A2 (en) | Isoxazolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
DE69431069T2 (en) | CYCLIC AMID DERIVATIVES AS NEUROKININ A ANTAGONISTS | |
IL163625A0 (en) | Alkoxy-pyridine derivatives and pharmaceutical compositions containing the same | |
AU591165B2 (en) | Angiotensin converting enzyme inhibitors | |
MX9804052A (en) | Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) | |
HUP0103316A2 (en) | 2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use | |
DK0628040T3 (en) | Indole derivatives as steroid 5alpha reductase inhibitors | |
BR0007729A (en) | Compound, pharmaceutical composition, and methods of controlling bacterial infections in a host in need of such therapy, and preparation of a compound | |
DE59304311D1 (en) | N-SUBSTITUTED 3-AZABICYCLO [3.2.0] HEPTANE DERIVATIVES AS A NEUROLEPTIC | |
NZ220195A (en) | 2-pyridyl-penem derivatives and pharmaceutical compositions | |
HUP0004317A2 (en) | 5-ht1f agonists | |
DE69314649T2 (en) | CHINUCLIDINE DERIVATIVES AS SQUAL SYNTHASE INHIBITORS | |
DK115491A (en) | OEPHENYLAA (3-PYRIDINYL) METHANON, OXIMARY DERIVATIVES | |
ES2001893A6 (en) | Methylendioxyphenathrene and stilben derivatives, process for the preparation thereof, pharmaceutical compositions using these, and therapeutic applications | |
NZ512891A (en) | S-oxide lipid lowering compounds | |
EA200200292A1 (en) | HYGROMYCIN DERIVATIVES | |
IL115085A0 (en) | Bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A E 9A ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009. |